Risk of mortality associated to chronic kidney disease in patients with complete left bundle branch block

Hui-Chun Huang1,2, Chun-Kai Chen3, Yen-Bin Liu1

  • 1Department of Internal Medicine, Division of Cardiology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.

Scientific Reports
|August 2, 2024
PubMed

Insights

Chronic kidney disease (CKD) significantly increases mortality risk in patients with complete left bundle branch block (cLBBB). Early identification and management of CKD in these patients are crucial for improving outcomes.

Area of Science:

  • Cardiology
  • Nephrology
  • Public Health

Background:

  • Chronic kidney disease (CKD) is a known risk factor for heart failure and cardiac conduction abnormalities.
  • Complete left bundle branch block (cLBBB) can worsen ventricular synchrony and contribute to heart failure progression.
  • A synergistic negative impact exists between CKD and heart failure, creating a detrimental cycle.

Purpose of the Study:

  • To investigate the impact of CKD on mortality in patients diagnosed with cLBBB.
  • To assess the role of estimated glomerular filtration rate (eGFR) in predicting outcomes for this patient group.

Main Methods:

  • A hospital-based cohort of 416 adult patients with cLBBB was analyzed retrospectively (2010-2013).
  • Estimated glomerular filtration rate (eGFR) was calculated using the CKD-EPI equation.
  • Cox proportional hazard models were employed to determine predictors of all-cause and cardiovascular mortality.

Main Results:

  • Advanced CKD (eGFR < 60 mL/min/1.73 m²) was a significant independent predictor of total mortality in patients with cLBBB.
  • The presence of CKD in cLBBB patients substantially increased the risk of both total mortality (HR 5.01) and cardiovascular death (HR 61.78) compared to those without CKD.
  • Older age, congestive heart failure, higher heart rate, and lack of ACEI/ARB use also predicted higher total mortality.

Conclusions:

  • CKD is a critical risk factor for increased all-cause mortality in individuals with cLBBB.
  • The findings highlight the importance of considering renal function when managing patients with cLBBB to mitigate mortality risks.

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: &#946;-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
326
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
406
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
353
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
68